Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
Sponsor: Muhammad Aamir Latif
Summary
Although, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contributing to standardized treatment protocols and improved survival rates.
Key Details
Gender
All
Age Range
2 Months - 12 Years
Study Type
INTERVENTIONAL
Enrollment
122
Start Date
2026-01-01
Completion Date
2026-06-30
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
Intravenous Hydrocortisone
Children will receive early intravenous hydrocortisone at 2 mg/kg/day divided every 6 hours, continued for 7 days or until resolution of shock.
Standard care
The children will be managed by following standard institutional treatment protocol.
Locations (1)
Abbasi Shaheed Hospital
Karachi, Sindh, Pakistan